Clinical Trials Logo

Covid19 clinical trials

View clinical trials related to Covid19.

Filter by:
  • Enrolling by invitation  
  • Page 1 ·  Next »

NCT ID: NCT05689177 Enrolling by invitation - Humoral Immunity Clinical Trials

Humoral Immunity Study After Booster Vaccination of "Soberana Plus" (The Republic of Cuba) Against COVID-19

Start date: December 9, 2022
Phase: N/A
Study type: Interventional

To evaluate the dynamics of IgG levels to the SARS-CoV-2 virus after a booster dose of Soberana Plus vaccine.

NCT ID: NCT05677984 Enrolling by invitation - COVID-19 Clinical Trials

Awaken Prone Positioning Ventinlation in COVID-19 Patients

Start date: January 1, 2023
Phase: N/A
Study type: Interventional

Awaken prone positioning (APP) ventilation has been widely accepted as a standard regimen in the management of COVID-19 patients. Physiological studies have proved ventilation/perfusion improvement during APP in COVID-19, which was associated improved oxygenation. However, the optimal duration for APP was not yet demonstrated. In this study, we aimed at the prolonged APP to see whether this could improve patients outcomes.

NCT ID: NCT05667597 Enrolling by invitation - COVID-19 Clinical Trials

Sars-COV-2 (COVID-19) Immunity in immunoCOmpromised Populations

COVICO
Start date: January 23, 2023
Phase: N/A
Study type: Interventional

The immune response of COVID-19 vaccination was monitored and studied in the context of the previously PICOV study (P2020/424), Nephro- VAC studies (P2020/284 and P2020/312) and Lung-VAC study (P2021/182). The constant emergence of new variants of concern (VOCs), which become increasingly better at escaping infection and vaccine induced immune responses, together with waning immunity over time, warrant additional vaccination rounds. This is especially true in immunocompromised populations. In the current study, we want to continue monitoring SARS-CoV-2 specific immunity over the next two years, encompassing several future vaccination campaigns.

NCT ID: NCT05621226 Enrolling by invitation - COVID-19 Clinical Trials

Message Communicating Latest Data on COVID-19 Transmission in Patient's Area

Start date: November 3, 2022
Phase: N/A
Study type: Interventional

This experiment is part of a megastudy with a total of ten experimental conditions and a holdout control condition to which patients will be randomly assigned. The focal comparison in this experiment is between a message encouraging vaccination by communicating to patients that they live in an area with significant COVID transmission and a control message telling patients that an updated COVID booster vaccine is waiting for them.

NCT ID: NCT05618600 Enrolling by invitation - COVID-19 Clinical Trials

Scripps-eMed Covid-19 Study: A Prospective Monitoring Study for Those Individuals Treated With Paxlovid

Start date: August 4, 2022
Phase:
Study type: Observational

A prospective monitoring study for those individuals treated with Paxlovid

NCT ID: NCT05613764 Enrolling by invitation - COVID-19 Clinical Trials

Message From Local Pharmacy Team

Start date: November 3, 2022
Phase: N/A
Study type: Interventional

This experiment is part of a megastudy with a total of ten experimental conditions and a holdout control condition to which patients will be randomly assigned. The focal comparison in this experiment is between a message encouraging vaccination that comes from a patient's local pharmacy team and a control message telling patients that an updated COVID booster vaccine is waiting for them. The intervention testing if text messages encouraging vaccination that come from a patient's local pharmacy team will produce more vaccinations than otherwise identical messages.

NCT ID: NCT05612386 Enrolling by invitation - COVID-19 Clinical Trials

Planning Message Recommending Same Time/Location as Last Vaccine

Start date: November 3, 2022
Phase: N/A
Study type: Interventional

This experiment is part of a megastudy with a total of ten experimental conditions and a holdout control condition to which patients will be randomly assigned. The focal comparison in this experiment is between a message suggesting the same day of the week, at the same time of day, and at the same pharmacy location as their last vaccination and a control message telling patients that an updated COVID booster vaccine is waiting for them. The intervention testing if text messages encouraging vaccination by suggesting patients receive a shot on the same day of the week, at the same time of day, and at the same pharmacy location as their last vaccination will produce more vaccinations than otherwise identical messages.

NCT ID: NCT05612373 Enrolling by invitation - COVID-19 Clinical Trials

Message Offering Free Round Trip Ride-Share Ride to Pharmacy

Start date: November 3, 2022
Phase: N/A
Study type: Interventional

This experiment is part of a megastudy with a total of ten experimental conditions and a holdout control condition to which patients will be randomly assigned. The focal comparison in this experiment is between a message encouraging vaccination that provides patients with a free round trip ride-share ride to and from any pharmacy near them and a control message telling patients that an updated COVID booster vaccine is waiting for them.

NCT ID: NCT05612360 Enrolling by invitation - COVID-19 Clinical Trials

Message Encouraging Vaccination in Preparation for the Holidays

Start date: November 3, 2022
Phase: N/A
Study type: Interventional

This experiment is part of a megastudy with a total of ten experimental conditions and a holdout control condition to which patients will be randomly assigned. Ther focal comparison in this experiment is between a message encouraging vaccination by reminding participants that the holiday season is just a few weeks away and getting vaccinated will allow them to more safely gather with loved ones and a control message telling patients that an updated COVID booster vaccine is waiting for them. The intervention testing if text messages encouraging vaccination by reminding participants that the holiday season is just a few weeks away and getting vaccinated will allow them to more safely gather with loved ones will produce more vaccinations than otherwise identical messages.

NCT ID: NCT05607082 Enrolling by invitation - COVID-19 Clinical Trials

COVID-19 Bivalent Booster Megastudy

Start date: November 3, 2022
Phase: N/A
Study type: Interventional

This megastudy is a massive randomized controlled trial. By randomizing participants to 10 different intervention conditions simultaneously, the investigators will be able to compare the effectiveness of different interventions to one another and to a control group (in which individuals will only receive the usual communications from their partner organization) to identify which interventions significantly increase vaccination rates. Pharmacy customers will be randomly assigned to receive one of the interventions designed by team scientists to encourage vaccination or to a control group. The baseline intervention will be based on the top-performing SMS intervention identified in the investigators previous megastudies on encouraging vaccination (Milkman et al., 2021b, 2022). Pharmacy customers will receive SMS messages conveying that a COVID booster vaccine is reserved or waiting for them at the pharmacy. Additional behavioral science messaging strategies will be tested by building off of this baseline intervention.